QT
ADVM

Quantbot Technologies’s Adverum Biotechnologies ADVM Stock Holding History

Quantbot Technologies’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-3,140
Closed -$109K – 1473
2021
Q2 		$109K Buy
+3,140
New +$169K 0.01% 888
2020
Q4 		– Sell
-950
Closed -$97K – 1238
2020
Q3 		$97K Buy
+950
New +$142K 0.01% 731
2019
Q3 		– Sell
-180
Closed -$21K – 1239
2019
Q2 		$21K Buy
+180
New +$14.9K ﹤0.01% 1032
2015
Q3 		– Sell
-80
Closed -$12K – 1165
2015
Q2 		$12K Sell
80
-138
-63% -$46.6K ﹤0.01% 977
2015
Q1 		$88K Buy
+218
New +$92.2K 0.02% 642

Other funds holding ADVM

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SFI
Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Quantbot Technologies's ADVM Position: Q3 2021 in Review

Quantbot Technologies sold out of Adverum Biotechnologies (ADVM) in Q3 2021, closing a stake of 3,140 shares — an estimated $109K sold.

Quantbot Technologies first reported a position in ADVM in Q1 2015 and held it in 5 quarters. The position peaked at $109K in Q2 2021. 110 funds tracked by Wall St. Rank hold ADVM as of Q3 2021.

  • Quantbot Technologies reported no remaining Adverum Biotechnologies position as of Q3 2021 after selling out during the quarter.
  • Quantbot Technologies sold 3,140 Adverum Biotechnologies shares in Q3 2021, an estimated $109K.
  • Quantbot Technologies first reported a position in Adverum Biotechnologies in Q1 2015 and held it in 5 quarters.
  • Quantbot Technologies's Adverum Biotechnologies position peaked at $109K in Q2 2021.
  • 110 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q3 2021.

Based on Quantbot Technologies's 13F filing for Q3 2021, filed 9 Nov 2021.